Loading clinical trials...
Loading clinical trials...
Currently, olanzapine is the most widely used and studied drug for the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease, but there are significant side effects. ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tianjin Anding Hospital
NCT07403370 · Solid Tumours, Olanzapine, and more
NCT06314906 · Electroacupuncture, Olanzapine-contained Four-drug Antiemetic, and more
NCT04892199 · Metabolic Disturbance, Schizophrenia, and more
NCT06523309 · BPSD (Behavioral and Psycological Symptoms of Dementia), Alzheimer's Dementia
NCT06359704 · BPSD, Expressed Emotion, and more
Tianjin Anding Hospital
Tianjin, Tianjin Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions